Medtronic Plc (MDT)

87.30
NYSE : Health Technology
Prev Close 87.60
Day Low/High 86.31 / 88.62
52 Wk Low/High 76.41 / 100.15
Avg Volume 5.85M
Exchange NYSE
Shares Outstanding 1.34B
Market Cap 117.65B
EPS 2.30
P/E Ratio 52.46
Div & Yield 2.00 (2.25%)

Latest News

Brinks, Medtronic, Fiat Chrysler: 'Mad Money' Lightning Round

Brinks, Medtronic, Fiat Chrysler: 'Mad Money' Lightning Round

Jim Cramer weighs in on Brinks, Sangamo Biosciences, Medtronic, Fiat Chrysler, GW Pharmaceuticals, EPR Properties.

Hunt for Winning Stocks: Cramer's 'Mad Money' Recap (Monday 1/7/19)

Hunt for Winning Stocks: Cramer's 'Mad Money' Recap (Monday 1/7/19)

Jim Cramer says companies that innovate become market-leading stocks, and can create tremendous wealth.

Medtronic, Stamps.com, Transocean: 'Mad Money' Lightning Round

Medtronic, Stamps.com, Transocean: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Medtronic, Stamps.com, Transocean, Kraft Heinz, HMS Holdings, Centene and more.

Medtronic Has Outperformed During This Correction, but Is It a Buy Now?

Medtronic has many of the characteristics of a high-quality dividend stock.

8 Top Year-End Trading Ideas for Bargain Hunters

8 Top Year-End Trading Ideas for Bargain Hunters

These eight S&P 500 stocks have some of the worst returns year-to-date and represent a diverse roster of promising bounce candidates.

Medtronic Is Testing the 200-Day Average and I Am Not Too Optimistic

Medtronic Is Testing the 200-Day Average and I Am Not Too Optimistic

Prices are testing the October and November lows and also testing the rising 200-day moving average line.

Hormel, Medtronic, Cisco and More: 'Mad Money' Lightning Round

Hormel, Medtronic, Cisco and More: 'Mad Money' Lightning Round

Jim Cramer weighs in on Hormel, Medtronic, Cisco and more.

The Fed Is Wrong: Cramer's 'Mad Money' Recap (Thursday 12/20/18)

The Fed Is Wrong: Cramer's 'Mad Money' Recap (Thursday 12/20/18)

Jim Cramer says the market pain will eventually end, once the Fed sees the error of its ways.

Rattled? The Only Obstacle Is the One in Front of You: Market Recon

Rattled? The Only Obstacle Is the One in Front of You: Market Recon

Everyone gets knocked down. What is different about you is that you are as tough as these markets.

Mazor Robotics Shareholders Approve Merger Agreement With Medtronic

Mazor Robotics Shareholders Approve Merger Agreement With Medtronic

CAESAREA, Israel, Nov. 19, 2018 /PRNewswire/ -- Mazor Robotics Ltd.

Real Money Post-Industrial Average Beat Nasdaq Comp in November's First Half

Real Money Post-Industrial Average Beat Nasdaq Comp in November's First Half

Our index of 30 cutting-edge companies fell ... but not as much as the Nasdaq did.

Microsoft, Medtronic, Raytheon: 'Mad Money' Lightning Round

Microsoft, Medtronic, Raytheon: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Microsoft, Medtronic, Raytheon, United Technologies, Xilinx, Cisco Systems.

As Good As it Gets?: Cramer's 'Mad Money' Recap (Monday 10/15/18)

As Good As it Gets?: Cramer's 'Mad Money' Recap (Monday 10/15/18)

Jim Cramer says the buzz on the trading floors all over the country is pretty simple: We are late in the cycle of economic expansion.

AT&T, Walmart, United Parcel Service: 'Mad Money' Lightning Round

AT&T, Walmart, United Parcel Service: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at AT&T, Walmart, United Parcel Service, FedEx, Comstock Resources, Intel, Teladoc, Mazor Robotics, Energy Transfer Partners.

Warming to Tariffs?: Cramer's 'Mad Money' Recap (Friday 9/21/18)

Warming to Tariffs?: Cramer's 'Mad Money' Recap (Friday 9/21/18)

Jim Cramer says maybe tariffs won't hit earnings or kill the rally mode. Plus, he's got your game plan for next week.

Information Mediary Corp Joins Medopad Global Digital Health Platform

Information Mediary Corp Joins Medopad Global Digital Health Platform

LONDON and OTTAWA, Oct. 23, 2018 /PRNewswire/ -  Medopad, a health technology company with partners such as Apple (NASDAQ: AAPL) and Tencent, is today announcing partnerships with leading health tech companies, including Medtronic (NYSE: MDT), Information...

Jim Cramer: Know Which Way the Wind Blows Before You Pick Stocks

Jim Cramer: Know Which Way the Wind Blows Before You Pick Stocks

PepsiCo, GE and just like the weather, the stock market is subject to change.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Medtronic To Acquire Mazor Robotics

Medtronic To Acquire Mazor Robotics

Acquisition to Accelerate Medtronic's Strategy to Transform Spinal Procedures and Improve Outcomes Through Fully-Integrated Surgical Solutions

Jim Cramer: Valuations Now Have No Relation to Common Sense

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.

3 Ways to Play Lululemon on This Rise: Market Recon

3 Ways to Play Lululemon on This Rise: Market Recon

LULU is up 70% since March. This is how to get into the name in an intelligent way.

Trump, the Fed, Kohl's, Nvidia and Amazon - 5 Things You Must Know

Trump, the Fed, Kohl's, Nvidia and Amazon - 5 Things You Must Know

U.S. stock futures post modest gains on Tuesday but the dollar extends its fall after Donald Trump criticizes the Federal Reserve for raising interest rates; Kohl's and TJX report earnings; Nvidia gets boost from new gaming chip; Amazon continues push into healthcare.

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®

United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.

Evercore Likes Becton Dickinson, Medtronic Ahead of Quarterly Results

Evercore Likes Becton Dickinson, Medtronic Ahead of Quarterly Results

Analyst Vijay Kumar names the stocks as his top picks among medical device companies as Wall Street heads into earnings season.

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

The heart-implant manufacturer is down some 4% over two days, but is up 128% year to date.

Tech Alone Can't Save the Rally: Cramer's 'Mad Money' Recap (Tuesday 6/5/18)

Tech Alone Can't Save the Rally: Cramer's 'Mad Money' Recap (Tuesday 6/5/18)

Jim Cramer says the tech titans are leading the way, but out side of the tech sector, very few stocks are following.

Medtronic: Cramer's Top Takeaways

Medtronic: Cramer's Top Takeaways

Omar Ishrak, chairman and CEO of Medtronic, tells Jim Cramer about advances in cardiac and metabolic technologies.

TheStreet Quant Rating: B (Buy)